BI Asset Management Fondsmaeglerselskab A S Acquires New Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

BI Asset Management Fondsmaeglerselskab A S purchased a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 101,415 shares of the pharmacy operator's stock, valued at approximately $946,000.

Other institutional investors have also recently made changes to their positions in the company. Dimensional Fund Advisors LP boosted its holdings in Walgreens Boots Alliance by 17.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,823,924 shares of the pharmacy operator's stock worth $17,016,000 after buying an additional 272,895 shares during the period. First Trust Advisors LP bought a new position in shares of Walgreens Boots Alliance in the fourth quarter worth about $368,000. Forum Financial Management LP grew its position in shares of Walgreens Boots Alliance by 71.2% during the fourth quarter. Forum Financial Management LP now owns 19,725 shares of the pharmacy operator's stock worth $184,000 after purchasing an additional 8,206 shares in the last quarter. GeoWealth Management LLC raised its stake in Walgreens Boots Alliance by 121.4% during the 4th quarter. GeoWealth Management LLC now owns 26,520 shares of the pharmacy operator's stock valued at $247,000 after purchasing an additional 14,541 shares during the period. Finally, Callodine Capital Management LP lifted its holdings in Walgreens Boots Alliance by 25.0% in the 4th quarter. Callodine Capital Management LP now owns 1,030,882 shares of the pharmacy operator's stock worth $9,618,000 after purchasing an additional 205,882 shares in the last quarter. Institutional investors own 58.59% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on WBA. Evercore ISI lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a research report on Monday, January 13th. StockNews.com started coverage on shares of Walgreens Boots Alliance in a report on Sunday. They set a "hold" rating for the company. Wolfe Research upgraded Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their target price for the stock from $11.00 to $9.00 in a research report on Friday, February 28th. Finally, Royal Bank of Canada raised their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a report on Wednesday, January 15th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $10.59.

Walgreens Boots Alliance Trading Down 0.1 %

WBA traded down $0.02 during trading on Tuesday, reaching $10.96. The company had a trading volume of 1,871,145 shares, compared to its average volume of 20,955,043. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The business has a 50 day simple moving average of $10.95 and a 200-day simple moving average of $10.24. The stock has a market cap of $9.47 billion, a P/E ratio of -1.07, a PEG ratio of 1.31 and a beta of 0.67. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $18.83.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $38.59 billion for the quarter, compared to the consensus estimate of $37.90 billion. During the same quarter in the prior year, the firm posted $1.20 earnings per share. The business's revenue for the quarter was up 4.1% on a year-over-year basis. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.